APO Research
Talk to an analyst

APO RESEARCH · REPORT

Thebaine

Thebaine, also known as paramorphine, is a white, crystalline, slightly water-soluble (in pure form after a synthesis), poisonous alkaloid. Thebaine is not used therapeutically, but as the main alkaloid extracted from papaver bracteatum (Iranian poppy), it can be converted industrially into a variety of compounds including oxycodone, oxymorphone, nalbuphine, naloxone, naltrexone, buprenorphine and etorphine.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Thebaine, also known as paramorphine, is a white, crystalline, slightly water-soluble (in pure form after a synthesis), poisonous alkaloid. Thebaine is not used therapeutically, but as the main alkaloid extracted from papaver bracteatum (Iranian poppy), it can be converted industrially into a variety of compounds including oxycodone, oxymorphone, nalbuphine, naloxone, naltrexone, buprenorphine and etorphine.

Selected research

Market Outlook & Growth Opportunities

Global Thebaine Market Outlook and Growth Opportunities 2026

22 December 2025193 pages

Choose your research edition.

Industry ResearchThebaine Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Thebaine Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Thebaine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Thebaine Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Thebaine Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

Thebaine, also known as paramorphine, is a white, crystalline, slightly water-soluble (in pure form after a synthesis), poisonous alkaloid. Thebaine is not used therapeutically, but as the main alkaloid extracted from papaver bracteatum (Iranian poppy), it can be converted industrially into a variety of compounds including oxycodone, oxymorphone, nalbuphine, naloxone, naltrexone, buprenorphine and etorphine.

Global Thebaine key players include Sun Pharmaceutical, Alcaliber, Tasmanian Alkaloids, TPI, Cepia-Sanofi, etc. Global top five manufacturers hold a share over 95%.

United States is the largest market, with a share over 40%, followed by Spain and Australia, both have a share over 55%.

Read the full market overview

In terms of product, Extraction from Poppy Straw is the largest segment, with a share over 95%. And in terms of application, the largest application is Oxycodone, followed by Hydrocodone, Buprenorphine, etc.

This report provides an overview of the global Thebaine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Thebaine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Thebaine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Thebaine market size, projected growth trends, production technologies, key applications, and end-use industries.

Thebaine Segment by Company

Sun Pharmaceutical

Tasmanian Alkaloids

Alcaliber

TPI

Cepia-Sanofi

Taj Pharmaceuticals

Gansu Alkaloids

Thebaine Segment by Type

Extraction from Poppy Straw

Extraction from Opium

Thebaine Segment by Application

Oxycodone

Hydrocodone

Buprenorphine

Others

Thebaine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Thebaine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Thebaine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Thebaine significant trends, drivers, influence factors in global and regions.

6. To analyze Thebaine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Thebaine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Thebaine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Thebaine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Thebaine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Thebaine industry.

Chapter 3: Detailed analysis of Thebaine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Thebaine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Thebaine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Thebaine Industry Trends Table 2. Thebaine Industry Drivers Table 3. Thebaine Industry Opportunities and Challenges Table 4. Thebaine Industry Restraints Table 5. Global Thebaine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Thebaine Revenue Share by Company (2021-2026) Table 7. Global Thebaine Sales Volume by Company (MT) & (2021-2026) Table 8. Global Thebaine Sales Volume Share by Company (2021-2026) Table 9. Global Thebaine Average Price (USD/Kg) of Company (2021-2026) Table 10. Global Thebaine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Thebaine Key Company Manufacturing Base & Headquarters Table 12. Global Thebaine Company, Product Type & Application Table 13. Global Thebaine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Thebaine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Extraction from Poppy Straw Table 18. Significant Companies of Extraction from Opium Table 19. Global Thebaine Sales Volume by Type 2021 VS 2025 VS 2032 (MT) Table 20. Global Thebaine Sales Volume by Type (2021-2026) & (MT) Table 21. Global Thebaine Sales Volume by Type (2027-2032) & (MT) Table 22. Global Thebaine Sales Volume Share by Type (2021-2026) Table 23. Global Thebaine Sales Volume Share by Type (2027-2032) Table 24. Global Thebaine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Thebaine Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Thebaine Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Thebaine Sales Value Share by Type (2021-2026) Table 28. Global Thebaine Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Oxycodone Table 30. Significant Companies of Hydrocodone Table 31. Significant Companies of Buprenorphine Table 32. Significant Companies of Others Table 33. Global Thebaine Sales Volume by Application 2021 VS 2025 VS 2032 (MT) Table 34. Global Thebaine Sales Volume by Application (2021-2026) & (MT) Table 35. Global Thebaine Sales Volume by Application (2027-2032) & (MT) Table 36. Global Thebaine Sales Volume Share by Application (2021-2026) Table 37. Global Thebaine Sales Volume Share by Application (2027-2032) Table 38. Global Thebaine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Thebaine Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Thebaine Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Thebaine Sales Value Share by Application (2021-2026) Table 42. Global Thebaine Sales Value Share by Application (2027-2032) Table 43. Global Thebaine Sales by Region: 2021 VS 2025 VS 2032 (MT) Table 44. Global Thebaine Sales by Region (2021-2026) & (MT) Table 45. Global Thebaine Sales Market Share by Region (2021-2026) Table 46. Global Thebaine Sales by Region (2027-2032) & (MT) Table 47. Global Thebaine Sales Market Share by Region (2027-2032) Table 48. Global Thebaine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Thebaine Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Thebaine Sales Value Share by Region (2021-2026) Table 51. Global Thebaine Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Thebaine Sales Value Share by Region (2027-2032) Table 53. Global Thebaine Market Average Price (USD/Kg) by Region (2021-2026) Table 54. Global Thebaine Market Average Price (USD/Kg) by Region (2027-2032) Table 55. Global Thebaine Sales by Country: 2021 VS 2025 VS 2032 (MT) Table 56. Global Thebaine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Thebaine Sales by Country (2021-2026) & (MT) Table 58. Global Thebaine Sales Market Share by Country (2021-2026) Table 59. Global Thebaine Sales by Country (2027-2032) & (MT) Table 60. Global Thebaine Sales Market Share by Country (2027-2032) Table 61. Global Thebaine Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Thebaine Sales Value Market Share by Country (2021-2026) Table 63. Global Thebaine Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Thebaine Sales Value Market Share by Country (2027-2032) Table 65. Sun Pharmaceutical Company Information Table 66. Sun Pharmaceutical Business Overview Table 67. Sun Pharmaceutical Thebaine Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 68. Sun Pharmaceutical Thebaine Product Portfolio Table 69. Sun Pharmaceutical Recent Development Table 70. Tasmanian Alkaloids Company Information Table 71. Tasmanian Alkaloids Business Overview Table 72. Tasmanian Alkaloids Thebaine Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 73. Tasmanian Alkaloids Thebaine Product Portfolio Table 74. Tasmanian Alkaloids Recent Development Table 75. Alcaliber Company Information Table 76. Alcaliber Business Overview Table 77. Alcaliber Thebaine Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 78. Alcaliber Thebaine Product Portfolio Table 79. Alcaliber Recent Development Table 80. TPI Company Information Table 81. TPI Business Overview Table 82. TPI Thebaine Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 83. TPI Thebaine Product Portfolio Table 84. TPI Recent Development Table 85. Cepia-Sanofi Company Information Table 86. Cepia-Sanofi Business Overview Table 87. Cepia-Sanofi Thebaine Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 88. Cepia-Sanofi Thebaine Product Portfolio Table 89. Cepia-Sanofi Recent Development Table 90. Taj Pharmaceuticals Company Information Table 91. Taj Pharmaceuticals Business Overview Table 92. Taj Pharmaceuticals Thebaine Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 93. Taj Pharmaceuticals Thebaine Product Portfolio Table 94. Taj Pharmaceuticals Recent Development Table 95. Gansu Alkaloids Company Information Table 96. Gansu Alkaloids Business Overview Table 97. Gansu Alkaloids Thebaine Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 98. Gansu Alkaloids Thebaine Product Portfolio Table 99. Gansu Alkaloids Recent Development Table 100. Key Raw Materials Table 101. Raw Materials Key Suppliers Table 102. Thebaine Distributors List Table 103. Thebaine Customers List Table 104. Research Programs/Design for This Report Table 105. Authors List of This Report Table 106. Secondary Sources Table 107. Primary Sources List of Figures Figure 1. Thebaine Product Image Figure 2. Global Thebaine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Thebaine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Thebaine Sales (2021-2032) & (MT) Figure 5. Global Thebaine Sales Average Price (USD/Kg) & (2021-2032) Figure 6. Global Thebaine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Extraction from Poppy Straw Image Figure 10. Extraction from Opium Image Figure 11. Global Thebaine Sales Volume by Type (2021 VS 2025 VS 2032) & (MT) Figure 12. Global Thebaine Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Thebaine Sales Volume Share by Type (2021-2032) Figure 14. Global Thebaine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Thebaine Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Thebaine Sales Value Share by Type (2021-2032) Figure 17. Oxycodone Image Figure 18. Hydrocodone Image Figure 19. Buprenorphine Image Figure 20. Others Image Figure 21. Global Thebaine Sales Volume by Application (2021 VS 2025 VS 2032) & (MT) Figure 22. Global Thebaine Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Thebaine Sales Volume Share by Application (2021-2032) Figure 24. Global Thebaine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Thebaine Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Thebaine Sales Value Share by Application (2021-2032) Figure 27. Global Thebaine Sales by Region: 2021 VS 2025 VS 2032 (MT) Figure 28. Global Thebaine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Thebaine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Thebaine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Thebaine Sales Value (2021-2032) & (US$ Million) Figure 32. North America Thebaine Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Thebaine Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Thebaine Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Thebaine Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Thebaine Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Thebaine Sales Value (2021-2032) & (US$ Million) Figure 38. South America Thebaine Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Thebaine Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Thebaine Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Thebaine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Thebaine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Thebaine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Thebaine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Thebaine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Thebaine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Thebaine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Thebaine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Thebaine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Thebaine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Thebaine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Thebaine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Thebaine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Thebaine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Thebaine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Thebaine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Thebaine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Thebaine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Thebaine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Thebaine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Thebaine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Thebaine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Thebaine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Thebaine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Thebaine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Thebaine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Thebaine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Thebaine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Thebaine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Thebaine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Thebaine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Thebaine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Thebaine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Thebaine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Thebaine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Thebaine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Thebaine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Thebaine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Thebaine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Thebaine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Thebaine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Thebaine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Thebaine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Thebaine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Thebaine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Thebaine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Thebaine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Thebaine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Thebaine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Thebaine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Thebaine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Thebaine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Thebaine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Thebaine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Thebaine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Thebaine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Thebaine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Thebaine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Thebaine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Thebaine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Thebaine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Thebaine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Thebaine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Thebaine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Thebaine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Thebaine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Thebaine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Thebaine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Thebaine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Thebaine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Thebaine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Thebaine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Thebaine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Thebaine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Thebaine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Thebaine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Thebaine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Thebaine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Thebaine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Thebaine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Thebaine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Thebaine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Thebaine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Thebaine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Thebaine Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Thebaine Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Extraction from Poppy Straw
  • Extraction from Opium
Applications
  • Oxycodone
  • Hydrocodone
  • Buprenorphine
  • Others
Companies covered
  • Sun Pharmaceutical
  • Tasmanian Alkaloids
  • Alcaliber
  • TPI
  • Cepia-Sanofi
  • Taj Pharmaceuticals
  • Gansu Alkaloids

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Thebaine Sales Value (2021-2032)
  4. 1.2.2 Global Thebaine Sales Volume (2021-2032)
  5. 1.2.3 Global Thebaine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Thebaine Market Dynamics
  1. 2.1 Thebaine Industry Trends
  2. 2.2 Thebaine Industry Drivers
  3. 2.3 Thebaine Industry Opportunities and Challenges
  4. 2.4 Thebaine Industry Restraints
3 Thebaine Market by Company
  1. 3.1 Global Thebaine Company Revenue Ranking in 2025
  2. 3.2 Global Thebaine Revenue by Company (2021-2026)
  3. 3.3 Global Thebaine Sales Volume by Company (2021-2026)
  4. 3.4 Global Thebaine Average Price by Company (2021-2026)
  5. 3.5 Global Thebaine Company Ranking (2024-2026)
  6. 3.6 Global Thebaine Company Manufacturing Base and Headquarters
  7. 3.7 Global Thebaine Company Product Type and Application
  8. 3.8 Global Thebaine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Thebaine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Thebaine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Thebaine Market by Type
  1. 4.1 Thebaine Type Introduction
  2. 4.1.1 Extraction from Poppy Straw
  3. 4.1.2 Extraction from Opium
  4. 4.2 Global Thebaine Sales Volume by Type
  5. 4.2.1 Global Thebaine Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Thebaine Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Thebaine Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Thebaine Sales Value by Type
  9. 4.3.1 Global Thebaine Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Thebaine Sales Value by Type (2021-2032)
  11. 4.3.3 Global Thebaine Sales Value Share by Type (2021-2032)
5 Thebaine Market by Application
  1. 5.1 Thebaine Application Introduction
  2. 5.1.1 Oxycodone
  3. 5.1.2 Hydrocodone
  4. 5.1.3 Buprenorphine
  5. 5.1.4 Others
  6. 5.2 Global Thebaine Sales Volume by Application
  7. 5.2.1 Global Thebaine Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Thebaine Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Thebaine Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Thebaine Sales Value by Application
  11. 5.3.1 Global Thebaine Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Thebaine Sales Value by Application (2021-2032)
  13. 5.3.3 Global Thebaine Sales Value Share by Application (2021-2032)
6 Thebaine Regional Sales and Value Analysis
  1. 6.1 Global Thebaine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Thebaine Sales by Region (2021-2032)
  3. 6.2.1 Global Thebaine Sales by Region: 2021-2026
  4. 6.2.2 Global Thebaine Sales by Region (2027-2032)
  5. 6.3 Global Thebaine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Thebaine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Thebaine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Thebaine Sales Value by Region (2027-2032)
  9. 6.5 Global Thebaine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Thebaine Sales Value (2021-2032)
  12. 6.6.2 North America Thebaine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Thebaine Sales Value (2021-2032)
  15. 6.7.2 Europe Thebaine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Thebaine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Thebaine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Thebaine Sales Value (2021-2032)
  21. 6.9.2 South America Thebaine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Thebaine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Thebaine Sales Value Share by Country, 2025 VS 2032
7 Thebaine Country-level Sales and Value Analysis
  1. 7.1 Global Thebaine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Thebaine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Thebaine Sales by Country (2021-2032)
  4. 7.3.1 Global Thebaine Sales by Country (2021-2026)
  5. 7.3.2 Global Thebaine Sales by Country (2027-2032)
  6. 7.4 Global Thebaine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Thebaine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Thebaine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Thebaine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Thebaine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Thebaine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Thebaine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Thebaine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Thebaine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Thebaine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Thebaine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Thebaine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Thebaine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Thebaine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Thebaine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Thebaine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Thebaine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Thebaine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Thebaine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Thebaine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Thebaine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Thebaine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Thebaine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Thebaine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Thebaine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Thebaine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Thebaine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Thebaine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Thebaine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Thebaine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Thebaine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Thebaine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Thebaine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Thebaine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Thebaine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Thebaine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Thebaine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Thebaine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Thebaine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Thebaine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Thebaine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Thebaine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Thebaine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Thebaine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Thebaine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Thebaine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Thebaine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Thebaine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Thebaine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Thebaine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Thebaine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Thebaine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Thebaine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Thebaine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Thebaine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Thebaine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Thebaine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Thebaine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Thebaine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Thebaine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Thebaine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Thebaine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Thebaine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Thebaine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Thebaine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Thebaine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Thebaine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Thebaine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Thebaine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Thebaine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Thebaine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Thebaine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Thebaine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Thebaine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Thebaine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Thebaine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Thebaine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Thebaine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Thebaine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Thebaine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Thebaine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Thebaine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Thebaine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Thebaine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Thebaine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Thebaine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Thebaine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sun Pharmaceutical
  2. 8.1.1 Sun Pharmaceutical Company Information
  3. 8.1.2 Sun Pharmaceutical Business Overview
  4. 8.1.3 Sun Pharmaceutical Thebaine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Sun Pharmaceutical Thebaine Product Portfolio
  6. 8.1.5 Sun Pharmaceutical Recent Developments
  7. 8.2 Tasmanian Alkaloids
  8. 8.2.1 Tasmanian Alkaloids Company Information
  9. 8.2.2 Tasmanian Alkaloids Business Overview
  10. 8.2.3 Tasmanian Alkaloids Thebaine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Tasmanian Alkaloids Thebaine Product Portfolio
  12. 8.2.5 Tasmanian Alkaloids Recent Developments
  13. 8.3 Alcaliber
  14. 8.3.1 Alcaliber Company Information
  15. 8.3.2 Alcaliber Business Overview
  16. 8.3.3 Alcaliber Thebaine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Alcaliber Thebaine Product Portfolio
  18. 8.3.5 Alcaliber Recent Developments
  19. 8.4 TPI
  20. 8.4.1 TPI Company Information
  21. 8.4.2 TPI Business Overview
  22. 8.4.3 TPI Thebaine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 TPI Thebaine Product Portfolio
  24. 8.4.5 TPI Recent Developments
  25. 8.5 Cepia-Sanofi
  26. 8.5.1 Cepia-Sanofi Company Information
  27. 8.5.2 Cepia-Sanofi Business Overview
  28. 8.5.3 Cepia-Sanofi Thebaine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Cepia-Sanofi Thebaine Product Portfolio
  30. 8.5.5 Cepia-Sanofi Recent Developments
  31. 8.6 Taj Pharmaceuticals
  32. 8.6.1 Taj Pharmaceuticals Company Information
  33. 8.6.2 Taj Pharmaceuticals Business Overview
  34. 8.6.3 Taj Pharmaceuticals Thebaine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Taj Pharmaceuticals Thebaine Product Portfolio
  36. 8.6.5 Taj Pharmaceuticals Recent Developments
  37. 8.7 Gansu Alkaloids
  38. 8.7.1 Gansu Alkaloids Company Information
  39. 8.7.2 Gansu Alkaloids Business Overview
  40. 8.7.3 Gansu Alkaloids Thebaine Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Gansu Alkaloids Thebaine Product Portfolio
  42. 8.7.5 Gansu Alkaloids Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Thebaine Value Chain Analysis
  2. 9.1.1 Thebaine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Thebaine Sales Mode & Process
  6. 9.2 Thebaine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Thebaine Distributors
  9. 9.2.3 Thebaine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst